The Global Vitreoretinal Surgery Devices Market size in 2023 is USD 1.69 billion. The market share is projected to grow at a CAGR of 3.04% and reach USD 2.15 billion by 2031.
Vitreoretinal diseases are conditions that affect structures in the eye called the retina and the vitreous. The retina is the light-sensitive layer in the back of the eye that focuses images and transmits that information to the brain via the optic nerve. The vitreous is a clear gel that fills the space between the lens (in the front of the eye) and the retina. The global vitreoretinal surgery devices market is experiencing significant growth, fueled by the escalating incidence of retinal diseases such as diabetic retinopathy and age-related macular degeneration (AMD). With the World Health Organization reporting that at least 2.2 billion people worldwide suffer from near or distance vision impairment, the demand for advanced vitreoretinal surgical solutions is more pressing than ever. This surge in market expansion is driven by aging population and increasing diabetes rates, which are contributing to higher prevalence of these debilitating retinal conditions. As a result, innovations in surgical technology and imaging systems are pivotal in addressing this global vision health crisis, providing new opportunities for market development and improved patient outcomes.
Data Bridge Market Research Market Report provides details of new recent developments, market share, market trends on the basis of its segmentations and regional analysis, the impact of market players, analyses of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research’s team of expert analysts. Our team will help you make informed market decisions to achieve business growth.
Global Vitreoretinal Surgery Devices Market Analysis and Market Size
|
Global Vitreoretinal Surgery Devices Market Report Metric Details
|
|
|
|
Report Metric
|
Details
|
|
|
Forecast Period
|
2024-2031
|
|
|
Base Year
|
2023
|
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
|
Measuring Unit
|
USD Billion
|
|
|
Data Pointers
|
Market value, growth rate, market segments, geographical coverage, market players, and market scenario, in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
|
Advances in surgical instruments, imaging systems, and laser technologies are revolutionizing the field, enabling more accurate diagnosis and effective treatment of retinal disorders. These cutting-edge technologies are not only improving surgical performance but also addressing the growing need for advanced solutions amidst increasing rates of retinal diseases, such as diabetic retinopathy and age-related macular degeneration (AMD). As a result, Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Phobic Disorders Treatment Market is increasing at a CAGR of 3.04%. Our detailed analysis forecasts that the market is valued at USD 1.69 billion in 2023 and is expected to grow upto USD 2.15 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.
Global Vitreoretinal Surgery Devices Market Dynamics
Global Vitreoretinal Surgery Devices Market Growth Drivers
Rise in Aging Population
Aging global population is significantly contributing to the increased prevalence of retinal diseases. For instance, age-related macular degeneration (AMD) is a leading cause of vision loss in individuals aged 50 and older. According to the National Eye Institute, AMD affects more than 2.1 million Americans. As our population ages, and the “baby boomers” advance into their 60's and 70's, the National Eye Institute estimates 3.7 million Americans will have moderate to severe AMD by 2030. Such demographic shift underscores the growing demand for advanced vitreoretinal surgical solutions to address the needs of an expanding population affected by age-related vision conditions. Consequently driving Global Vitreoretinal Surgery Devices Market growth.
Rising Organizational support
The increasing prevalence of diabetes is a significant driver for the global vitreoretinal surgery devices market. According to the International Diabetes Federation (IDF), the number of adults aged 20–79 living with diabetes is projected to rise from 537 million in 2021 to 643 million by 2030 and reach 783 million by 2045. As diabetes becomes more widespread, diabetic retinopathy, a common complication that is a leading cause of vision impairment, becomes more prevalent. Such surge in diabetic cases directly fuels the demand for advanced vitreoretinal surgical solutions to manage and treat diabetic.
Global Vitreoretinal Surgery Devices Market Growth Opportunities
Robotic-Assisted Surgery
The integration of robotic-assisted surgical systems into vitreoretinal procedures represents a transformative advancement, significantly enhancing both precision and efficiency. For instance, the use of the NGENUITY 3D Visualization System, which combines robotic assistance with high-definition 3D visualization, allows for intricate maneuvers and better visualization of the retinal anatomy, leading to more precise surgical interventions. As robotic-assisted technologies continue to evolve, they present substantial opportunities in the global vitreoretinal surgery devices market growth.
Growing need for efficiency and accuracy
Stellaris Elite by Bausch + Lomb utilizes hypersonic technology to offer unprecedented precision and control during vitreoretinal procedures. By operating at high frequencies, it allows for more accurate manipulation of retinal tissues and efficient removal of vitreous gel, enhancing surgical outcomes and reducing recovery times. The increases in demand for advanced, high-performance surgical tools fosters the Global Vitreoretinal Surgery Devices Market growth.
Global Vitreoretinal Surgery Devices Market Growth Challenges
Technological Obsolescence
The swift pace of technological advancement in vitreoretinal surgery presents a major challenge, as it can lead to frequent updates and potential obsolescence of existing devices. For instance, innovations such as high-definition 3D visualization systems and AI-driven diagnostic tools can quickly render older technologies outdated. This relentless evolution compels manufacturers to continually innovate and manage their product lifecycle effectively, navigating the complexities of keeping pace with technological progress while ensuring their devices remain competitive in the global market hampers the Global Vitreoretinal Surgery Devices Market growth.
Variability in Symptom Presentation
The growing availability of alternative treatments poses a significant challenge to the vitreoretinal surgery devices market, as pharmacological therapies and less invasive procedures may reduce the demand for traditional surgical interventions. For instance, the introduction of new anti-VEGF (vascular endothelial growth factor) drugs, such as Lucentis and Eylea, has provided effective pharmacological options for managing conditions like age-related macular degeneration (AMD) and diabetic retinopathy. These advancements in drug therapy can diminish the need for surgical procedures, impacting the Global Vitreoretinal Surgery Devices Market growth.
Global Vitreoretinal Surgery Devices Market Growth Restraints
Regulations restraining market expansion
In the European Union, the Medical Devices Regulation (MDR) mandates comprehensive documentation and rigorous conformity assessments, including the need for extensive clinical evaluations and post-market surveillance, as outlined in Regulation (EU) 2017/745. Such stringent regulatory requirements can extend the time-to-market for new technologies and increase the burden on manufacturers, potentially slowing the Global Vitreoretinal Surgery Devices Market Growth and innovation in the vitreoretinal surgery sector.
Global Vitreoretinal Surgery Devices Market Scope and Trends
|
Global Vitreoretinal Surgery Devices Market Segmentations Overview
|
|
|
Market
|
Sub-Segments
|
|
Product
|
Per fluoro carbon liquids, endoillumination instruments and vitreo retinal prefilled silicone oil syringes
|
|
Type
|
Illumination surgery devices, photocoagulation surgery devices and vitrectomy surgery devices
|
|
End use
|
hospitals, ambulatory surgical centers, and others
|
|
Application
|
Anterior vitreoretinal surgery, posterior vitreoretinal surgery
|
- Pars plana vitrectomy (PPV) is a common surgical method in vitreoretinal surgery that allows access to the eye's posterior segment to treat diseases such as retinal detachment, vitreous hemorrhage, and macular hole. The technique involves extracting vitreous fluid and scar tissue from the retina via the pars plana, which is an avascular region in the white of the eye.
- The megaTRON S4HPS is one of the most powerful ophthalmic surgery systems for the anterior and posterior segment. Its UNO Colorline MACH2 vitreous cutters enable cut rates of up to 12,000 cpm.
Global Vitreoretinal Surgery Devices Market Regional Analysis – Market Trends
|
Global Vitreoretinal Surgery Devices Market Regional Overview
|
|
|
|
Region
|
Countries
|
|
|
Europe
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
|
|
|
APAC
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
|
|
|
North America
|
U.S., Canada, and Mexico
|
|
|
MEA
|
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East, and Africa
|
|
|
South America
|
Brazil, Argentina, and Rest of South America
|
|
Key Insights
- The North American market leads with advanced healthcare infrastructure and high adoption of innovative technologies. The U.S. and Canada benefit from substantial R&D investments, a high prevalence of retinal diseases, and supportive reimbursement policies, driving strong market growth.
- Europe demonstrates robust growth, driven by high prevalence of retinal disorders and a supportive healthcare system. Despite stringent MDR regulations, major markets like Germany, France, and the UK are thriving as they embrace advanced vitreoretinal devices.
- The Asia-Pacific region is experiencing dynamic expansion, fueled by increasing healthcare investments and a rising prevalence of retinal diseases in countries like China and India. Enhanced awareness and improving medical infrastructure are accelerating market growth, with significant potential for innovation and adoption.
- Latin America is on an upward trajectory, supported by rising healthcare spending and improving infrastructure in Brazil and Mexico. Growing awareness of retinal diseases is boosting demand, presenting opportunities for market growth despite economic fluctuations and varying access to advanced technologies.
- In the Middle East and Africa, the market is expanding rapidly due to increased healthcare investments and a rising incidence of diabetic retinopathy, especially in the UAE and South Africa. This growth is creating promising opportunities, with ongoing improvements in healthcare access and infrastructure across the region.
Global Vitreoretinal Surgery Devices Market Leading Players
- Alcon, Inc.
- Allergan
- Bausch & Lomb, Inc.
- Carl Zeiss Meditec AG
- Dutch Ophthalmic Research Center International BV
- Glaukos Corporation
- Hoya Corporation
- ICON plc
- Inami & CO. Ltd.
- Johnson & Johnson Services, Inc.
- MedOne Surgical, Inc.
- New World Medical, Inc.
- Novartis AG
- Oertli Instrumente AG
- OCULUS
- Paragon Care Group Australia Pty Ltd.
- Peregrine Surgical
- STAAR SURGICAL
- ZEISS International
Global Vitreoretinal Surgery Devices Market Recent Developments
-
In December, 2023 Eurazeo, a French investment group, will sell Zeiss all of its shares in DORC. The acquisition will enable Zeiss to expand its offering of vitreoretinal surgical instruments.
- In June, 2024, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have received U.S. Food and Drug Administration (FDA) 510(k) clearance.
SKU-